American Heart Association

BEHAVIORAL2 trials

Sponsors

Clinica Universidad de Navarra, Universidad de Navarra, Auburn University

Conditions

Cardiovascular DiseaseCardiovascular DiseasesCardiovascular Risk FactorDiabetesMetabolic SyndromeObesity

Unknown Phase

Reduction of the Metabolic Syndrome in Navarra-Spain

CompletedNCT01087086

Clinica Universidad de Navarra, Universidad de NavarraCardiovascular Disease, Diabetes, Metabolic Syndrome +1

Start: 2010-01-31End: 2011-11-30Updated: 2016-05-12

A Mediterranean Diet Nutrition Education Program for the Reduction of Cardiovascular Disease Risk in the Southeastern U.S.

CompletedNCT03683134

Auburn UniversityCardiovascular Diseases, Cardiovascular Risk Factor, Obesity

Start: 2017-01-23End: 2017-09-07Updated: 2018-09-27

Related Papers

Changes in lysophospholipids and liver status after weight loss: the RESMENA study.

2018-07-1723 citations

LINE-1 methylation levels, a biomarker of weight loss in obese subjects, are influenced by dietary antioxidant capacity

Redox Report2015-07-2143 citations

A decline in inflammation is associated with less depressive symptoms after a dietary intervention in metabolic syndrome patients: a longitudinal study.

2014-04-2428 citations

Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet

PubMed2014-04-0936 citations

Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects.

2014-02-2450 citations

Longitudinal relationship of diet and oxidative stress with depressive symptoms in patients with metabolic syndrome after following a weight loss treatment: the RESMENA project.

2013-11-2225 citations

SERPINE1, PAI-1 protein coding gene, methylation levels and epigenetic relationships with adiposity changes in obese subjects with metabolic syndrome features under dietary restriction.

2013-10-3135 citations

Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial.

2013-02-1354 citations